IBRX Covered Call Strategy
IBRX (ImmunityBio, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
ImmunityBio, Inc. is a clinical-stage biotechnology firm, founded in 2014 and based in San Diego, California. The company is focused on developing groundbreaking therapies and vaccines designed to treat a wide array of cancers and infectious diseases. Its innovative approach relies on a comprehensive suite of immunotherapy and cell therapy platforms. These advanced technologies include novel antibody-cytokine fusion proteins, synthetically engineered immunomodulators, cutting-edge vaccine technologies, natural killer (NK) cell therapies, and strategies that harness the adaptive (T-cell) immune system. ImmunityBio currently has several therapeutic candidates in advanced clinical development, with agents undergoing Phase II or III trials. These investigational treatments are aimed at various liquid and solid tumors, such as bladder, pancreatic, and lung cancers, as well as significant infectious pathogens including SARS-CoV-2 and HIV.
IBRX (ImmunityBio, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $8.11B, a beta of 0.13 versus the broader market, a 52-week range of 1.95-12.43, average daily share volume of 13.0M, a public-listing history dating back to 2015, approximately 688 full-time employees. These structural characteristics shape how IBRX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.13 indicates IBRX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a covered call on IBRX?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
IBRX snapshot
As of August 14, 2026, spot at $7.54, ATM IV 71.40%, IV rank 27.86%, expected move 20.47%. The covered call on IBRX below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this covered call structure on IBRX specifically: IBRX IV at 71.40% is on the cheap side of its 1-year range, which means a premium-selling IBRX covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 20.47% (roughly $1.54 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IBRX expiries trade a higher absolute premium for lower per-day decay. Position sizing on IBRX should anchor to the underlying notional of $7.54 per share and to the trader's directional view on IBRX stock.
IBRX covered call setup
The IBRX covered call below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IBRX at $7.54 on that close, the first option leg uses a $8.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IBRX chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IBRX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $7.54 | long |
| Sell 1 | Call | $8.00 | $0.49 |
IBRX covered call risk and reward
- Net Premium / Debit
- -$705.00
- Max Profit (per contract)
- $95.00
- Max Loss (per contract)
- -$704.00
- Breakeven(s)
- $7.05
- Risk / Reward Ratio
- 0.135
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
IBRX covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on IBRX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -99.9% | -$704.00 |
| $1.68 | -77.8% | -$537.40 |
| $3.34 | -55.7% | -$370.79 |
| $5.01 | -33.6% | -$204.19 |
| $6.67 | -11.5% | -$37.59 |
| $8.34 | +10.6% | +$95.00 |
| $10.01 | +32.7% | +$95.00 |
| $11.67 | +54.8% | +$95.00 |
| $13.34 | +76.9% | +$95.00 |
| $15.00 | +99.0% | +$95.00 |
When traders use covered call on IBRX
Covered calls on IBRX are an income strategy run on existing IBRX stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
IBRX thesis for this covered call
The market-implied 1-standard-deviation range for IBRX extends from approximately $6.00 on the downside to $9.08 on the upside. A IBRX covered call collects premium on an existing long IBRX position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether IBRX will breach that level within the expiration window. Current IBRX IV rank near 27.86% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on IBRX at 71.40%. As a Healthcare name, IBRX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IBRX-specific events.
IBRX covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IBRX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IBRX alongside the broader basket even when IBRX-specific fundamentals are unchanged. Short-premium structures like a covered call on IBRX carry tail risk when realized volatility exceeds the implied move; review historical IBRX earnings reactions and macro stress periods before sizing. Always rebuild the position from current IBRX chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on IBRX?
- A covered call on IBRX is the covered call strategy applied to IBRX (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With IBRX stock at $7.54 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed IBRX chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are IBRX covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the IBRX covered call priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 71.40%), the computed maximum profit is $95.00 per contract and the computed maximum loss is -$704.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a IBRX covered call?
- The breakeven for the IBRX covered call priced on this page is roughly $7.05 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The IBRX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 20.47%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on IBRX?
- Covered calls on IBRX are an income strategy run on existing IBRX stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current IBRX implied volatility affect this covered call?
- IBRX ATM IV is at 71.40% with IV rank near 27.86%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.